Homocysteine levels among transplant recipients: effect of immunosuppressive protocols.
Mor
E
E
Department of Transplantation, Rabin Medical Center, Petach-Tikva, Israel.
Helfmann
L
L
Lustig
S
S
Bar-Nathan
N
N
Yussim
A
A
Sela
B A
BA
D016572:Cyclosporine / Q000627:therapeutic use; D005500:Follow-Up Studies; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D016031:Liver Transplantation / Q000276:immunology / Q000502:physiology*; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors
D007166:Immunosuppressive Agents; D006710:Homocysteine; D016572:Cyclosporine; D016559:Tacrolimus